YOLFTbeta
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd

000766 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

16.50CNY+1.50 (+10.00%)

Price History

Full chart

Market Stats

Previous Close15.00
Open14.91
Day Range14.91 – 16.50
52-Week Range14.94 – 30.20
Volume50.16M
Market Cap14.65B
P/E (TTM)505.33
Forward P/E147.06
EPS0.03
Dividend Yield0.00%
Beta0.56
50-Day Avg16.28
200-Day Avg21.44

About

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. The company provides anti-tumor drugs, gynecological medications, medication for rheumatic bone pain, urological medications, heat-clearing and detoxifying drugs, cardiovascular and cerebrovascular drugs, digestive medications, tonifying and restorative medicines, respiratory medication, diabetes medication, ENT medication, and pediatric medications. It also offers Xiaojin pills, Tian Ranshexiang Xiaojin pills, Xiaokechuan capsules, Jiuwei Qianghuo granules, Xiongdan powder, Bear Bile powder, and Wenweishu tablets to treat glandular hyperplasia, inflammatory diseases, bone trauma and soft tissue injury, and other related diseases. In addition, the company provides bacillus cereus live bacteria capsules, bacillus cereus live bacteria tablets are therapeutic live bacteria microecological preparations to treat enteritis, diarrhea, infantile diarrhea, and intestinal dysfunction. The company was founded in 1990 and is headquartered in Tonghua, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Yufu Zhang
  • Employees1.48K
  • HeadquartersNo. 999, Jinma Road, Tonghua, China, 134003, China
  • Websitehttps://www.thjm.cn

Leadership

  • Mr. Yufu ZhangGM & Chairman · b. 1962
  • Mr. Jun YuDeputy GM & CFO · b. 1971
  • Mr. Yu JingDeputy GM & Non-Independent Director · b. 1979
  • Mr. Hailong ZhangExecutive Vice President · b. 1963
  • Mr. Weilin JiaBoard Secretary · b. 1965
  • Mr. Xiaolang YuDeputy General Manager · b. 1970
  • Lan GengAccounting Supervisor

Financials

Income Statement

Currency: CNY1994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue99.44M132.49M163.87M241.07M270.99M284.91M504.19M100.43M161.00M136.90M99.87M141.15M141.34M151.59M159.86M168.16M169.59M179.14M127.65M147.78M208.41M197.56M850.08M1.52B2.09B1.98B1.11B1.52B1.47B1.47B1.32B1.17B
Growth (%)-+33.24%+23.68%+47.11%+12.41%+5.14%+76.96%-80.08%+60.30%-14.97%-27.05%+41.33%+0.13%+7.25%+5.45%+5.20%+0.85%+5.63%-28.74%+15.77%+41.03%-5.21%+330.29%+78.97%+37.67%-5.60%-43.77%+36.31%-2.95%+0.18%-10.23%-11.54%
Cost of Revenue49.94M50.47M47.68M75.39M114.28M103.89M70.48M30.47M39.43M50.14M49.70M58.78M66.03M67.13M64.34M65.56M65.85M76.35M58.02M72.23M79.38M96.45M265.26M324.87M339.40M343.84M229.94M350.18M352.93M381.17M329.03M326.03M
Gross Profit49.49M82.02M116.19M165.68M156.71M181.02M433.71M69.96M121.56M86.76M50.17M82.38M75.31M84.46M95.52M102.60M103.74M105.12M69.62M75.55M129.04M101.11M584.82M1.20B1.76B1.63B881.86M1.17B1.12B1.09B993.53M843.92M
Gross Margin49.78%61.90%70.90%68.73%57.83%63.54%86.02%69.66%75.51%63.37%50.24%58.36%53.28%55.72%59.75%61.01%61.17%58.68%54.54%51.12%61.91%51.18%68.80%78.65%83.80%82.61%79.32%76.89%76.00%74.13%75.12%72.13%
Operating Expense24.69M29.59M40.80M61.75M72.77M87.10M167.91M436.55M142.18M265.24M325.20M71.62M71.65M72.08M80.74M88.99M99.63M106.33M82.06M72.30M113.02M96.30M351.88M896.85M1.35B3.65B1.24B1.10B1.07B1.04B926.10M722.77M
Operating Income24.80M52.43M75.39M103.93M83.94M93.92M265.80M-366.59M-20.62M-178.48M-275.03M10.75M3.66M12.38M14.78M13.61M4.11M-1.21M-12.43M3.25M16.02M4.81M232.94M299.69M407.79M-2.01B-356.58M62.28M51.39M51.67M67.43M121.16M
Operating Margin24.94%39.57%46.01%43.11%30.98%32.96%52.72%-365.00%-12.81%-130.38%-275.38%7.62%2.59%8.17%9.24%8.09%2.42%-0.68%-9.74%2.20%7.69%2.43%27.40%19.70%19.47%-101.79%-32.07%4.11%3.49%3.51%5.10%10.36%
EBITDA27.56M51.54M79.89M112.94M109.05M116.02M386.58M-475.94M91.47M-132.44M-221.71M28.70M23.75M35.42M39.06M31.07M29.42M21.35M4.51M-6.91M12.96M-4.88M271.00M342.79M361.34M111.62M-278.53M182.72M192.58M196.49M204.82M187.03M
EBITDA Margin27.72%38.90%48.76%46.85%40.24%40.72%76.67%-473.88%56.81%-96.75%-222.00%20.33%16.81%23.37%24.43%18.48%17.35%11.92%3.53%-4.68%6.22%-2.47%31.88%22.53%17.25%5.65%-25.05%12.06%13.09%13.34%15.49%15.99%
Net Income22.85M46.86M66.00M95.48M65.68M81.35M241.91M-584.12M16.42M-194.27M-245.68M8.48M-8.57M18.83M17.18M29.79M12.02M11.24M3.86M4.09M5.17M6.86M213.46M257.88M330.86M-2.04B-359.50M35.27M30.15M43.93M56.44M34.29M
Net Income Margin22.98%35.37%40.27%39.61%24.24%28.55%47.98%-581.60%10.20%-141.91%-245.99%6.00%-6.06%12.42%10.75%17.72%7.09%6.28%3.02%2.77%2.48%3.47%25.11%16.95%15.80%-103.27%-32.33%2.33%2.05%2.98%4.27%2.93%
R&D-------------------710.00K2.07M7.93M28.58M57.53M67.30M66.91M50.33M63.52M64.91M45.82M58.93M39.85M
R&D as % of Total Revenue-------------------0.48%0.99%4.02%3.36%3.78%3.21%3.38%4.53%4.19%4.41%3.11%4.46%3.41%
Interest Expense2.80M4.13M4.40M9.11M6.78M9.89M44.41M55.36M60.01M44.90M48.20M5.61M2.68K42.74K1.47K15.18K20.65K5.98K41.42K2.69M4.90M2.19M18.94M28.83M39.89M49.10M123.16M97.77M88.79M83.15M82.78M81.89M
Interest Expense % of Total Revenue2.82%3.12%2.69%3.78%2.50%3.47%8.81%55.12%37.28%32.80%48.26%3.98%0.00%0.03%0.00%0.01%0.01%0.00%0.03%1.82%2.35%1.11%2.23%1.90%1.90%2.48%11.08%6.45%6.04%5.64%6.26%7.00%

Balance Sheet

Currency: CNY1994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets233.52M290.59M353.02M778.32M870.83M1.33B2.26B1.47B1.53B1.44B1.09B1.11B800.12M809.43M811.59M869.23M902.60M879.82M894.89M1.11B1.29B4.16B5.30B5.73B5.96B4.70B4.98B4.64B4.69B4.52B4.48B4.48B
Total Liabilities61.68M109.28M161.79M175.42M234.01M286.19M1.18B994.08M1.04B1.14B1.05B1.06B282.05M272.53M257.51M285.36M306.71M272.69M275.29M491.91M626.09M1.91B1.14B1.31B1.25B2.03B2.68B2.30B2.32B2.20B2.23B2.17B
Total Equity171.84M181.32M191.23M584.20M616.27M1.02B1.06B472.27M488.69M294.42M36.64M45.26M518.07M536.90M554.08M583.87M595.89M607.13M619.60M615.08M659.50M2.25B4.12B4.38B4.67B2.63B2.27B2.31B2.34B2.32B2.26B2.31B
Cash84.92M58.55M16.91M123.28M103.44M319.35M657.80M30.98M9.43M18.62M5.35M27.19M5.85M9.70M12.48M39.28M18.23M14.74M6.81M18.75M53.41M79.32M210.69M363.14M318.69M282.54M508.03M301.59M336.82M177.45M274.18M272.10M
Total Debt32.03M38.29M51.91M46.36M127.38M204.22M622.73M925.48M903.85M950.25M849.25M875.10M-------30.00M200.00M155.00M356.40M591.00M476.60M1.11B1.94B227.79M1.59B1.69B197.58M-
Net Debt-52.89M-20.26M35.00M-76.92M23.94M-115.14M-35.07M894.50M894.42M931.63M843.90M847.91M-5.85M-9.70M-12.48M-39.28M-18.23M-14.74M-6.81M11.25M146.59M75.68M145.71M227.86M157.91M830.67M1.44B-73.80M1.26B1.51B-76.60M1.53B

Cash Flow

Currency: CNY1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-62.93M-80.62M196.15M-740.34M72.70M91.99M19.12M35.74M-18.02M9.95M10.26M79.94M29.05M-7.93M-6.49M102.96M34.32M-160.95M90.63M26.43M170.72M74.86M80.71M138.33M198.16M112.78M162.75M105.05M
Investing Cash Flow-11.67M-63.48M-70.86M61.85M-17.28M-82.46M-4.35M-13.65M-3.32M-6.10M-7.48M-53.14M-50.10M4.44M-1.44M-198.16M-160.45M-382.61M-1.83B-157.17M-53.86M-814.30M-524.66M4.25M-21.24M73.13M-49.12M-
Financing Cash Flow54.55M360.01M244.29M53.63M-76.97M-259.32K-27.26M--------103.26M164.67M568.59M1.87B283.19M-164.49M703.29M580.00M-354.40M-144.42M-253.86M-6.89M-
Capital Expenditure12.65M63.51M360.49M16.41M17.31M82.57M4.37M17.55M3.68M5.12M7.48M13.14M10.20M8.14M19.41M157.66M183.39M28.07M169.40M118.10M74.40M60.98M19.16M25.48M23.74M26.67M49.17M64.07M
Free Cash Flow-75.58M-144.13M-164.33M-756.75M55.40M9.42M14.76M18.19M-21.69M4.83M2.78M66.80M18.85M-16.08M-25.90M-54.69M-149.07M-189.02M-78.77M-91.67M96.32M13.88M61.55M112.85M174.42M86.11M113.58M40.99M
Dividends Paid9.03M23.30M212.21M248.02M58.34M41.95M27.26M--------1.14M5.33M12.41M16.10M26.42M24.86M42.37M130.85M97.50M88.60M83.32M84.98M81.32M
FCF to OCF120.11%178.78%-83.78%102.22%76.20%10.24%77.17%50.89%120.41%48.53%27.10%83.56%64.88%202.65%398.87%-53.12%-434.39%117.44%-86.92%-346.78%56.42%18.54%76.26%81.58%88.02%76.36%69.79%39.02%
Dividend Paid to FCF-11.95%-16.16%-129.13%-32.77%105.32%445.48%184.69%---------2.09%-3.57%-6.57%-20.44%-28.82%25.81%305.28%212.59%86.39%50.80%96.76%74.82%198.39%

Earnings

Report DateMar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Oct 20, 2015Dec 31, 2015Apr 28, 2016Aug 18, 2016Oct 20, 2016Dec 31, 2016Apr 28, 2017Aug 17, 2017Oct 19, 2017Dec 31, 2017Apr 27, 2018Aug 17, 2018Oct 29, 2018Dec 31, 2018Apr 9, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 29, 2020Aug 20, 2020Oct 30, 2020Dec 31, 2020Apr 28, 2021Aug 20, 2021Oct 29, 2021Dec 31, 2021Apr 27, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Jun 17, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025
EPS Estimate--------------------------------------------------------------
EPS Actual0.010.020.01-0.010.030.010.01-0.020.020.00-0.010.000.02-0.01-0.00-0.000.04-0.02-0.01-0.000.03-0.02-0.00-0.000.050.040.040.080.060.070.050.090.060.080.040.160.050.070.04-2.28-0.05-0.03-0.09-0.210.000.02-0.010.020.010.000.010.020.010.000.000.030.010.000.010.030.010.01
Surprise--------------------------------------------------------------
Timing----------------------Pre-market-Pre-marketPre-marketPre-market-Pre-marketAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hours-----------Pre-market-------After-hours-----

Key Statistics & Ratios

Market Cap14.65B
Enterprise Value16.45B
Trailing P/E505.33
Forward P/E147.06
PEG Ratio0.00
Price / Sales13.60
Price / Book6.43
EPS0.03
Book Value2.40
Revenue (TTM)1.08B
Gross Profit (TTM)784.06M
EBITDA161.85M
Profit Margin2.28%
Operating Margin7.99%
Return on Equity1.06%
Return on Assets1.37%
Shares Outstanding966.49M
Shares Float702.15M
Beta0.56
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20011×
0.47May 25, 2001

Stock Splits

  • May 25, 20011.5:1
  • Sep 24, 19972:1